News by Subject Medicine & Health

Nurse practitioners are more likely to conduct HIV screenings if they feel that their colleagues support routine screenings, according to new research from Binghamton University, State University of New York. This comes in advance of National HIV Testing Day, taking place June 27, 2019.

Temple's Dr. Riyaz Bashir led a research team that sought to compare the outcomes associated with patients receiving prophylactic inferior vena cava filters (IVCF) prior to bariatric surgery to those who did not receive IVCFs. The team's findings suggest the practice of implanting the IVCFs on a prophylactic basis prior to bariatric surgery is associated with worse clinical outcomes and increased healthcare resource utilization.

Sickle cell disease is a form of anemia that is inherited when both parents are carriers of a mutation in the hemoglobin gene. Currently, it can only be diagnosed in pregnancy by carrying out an invasive test that has a small risk of miscarriage and is therefore sometimes declined by parents. Now, researchers have developed a noninvasive prenatal test for the disease.

A combination of six antibodies can successfully prepare mice to accept blood and immune stem cells from an immunologically mismatched donor, according to a study by researchers at the Stanford University School of Medicine.

Article signed by researchers affiliated with institutions in the US, UK, Ghana and Brazil highlights recent progress in diagnosis and treatment but warns that more screening of newborns is needed.

A new study has found that the sex or pregnancy history of red blood cell donors does not influence the risk of death among patients who receive their blood. The study adds to a growing body of literature examining whether blood donor characteristics such as sex, age, and pregnancy history affect the survival of transfused patients.

Whether blood donors' sex and pregnancy history were associated with death for red blood cell transfusion recipients was investigated in this study that analyzed data from three study groups totaling more than 1 million transfusion recipients.

Patients with chronic myeloid leukemia are treated with tyrosine kinase inhibitors. While these effective drugs lead to deep remission and prolonged survival, primitive leukemia stem cells resist elimination during the remission and persist as a major barrier to cure. In a study published in the Journal of Clinical Investigation, researchers show how the stress-responsive protein SIRT1 plays important roles in maintaining the regenerative potential of CML leukemic stem cells and promoting leukemia development in CML.

Researchers at Dana-Farber Cancer Institute and the VA Boston Healthcare System have uncovered a new vital sign for gauging survival and likelihood of having an unplanned hospitalization in older patients with blood cancers: the speed at which they can walk.